Latin American Journal of Pharmacy



 
 
 Vol. 36 Nš 9
Lat. Am. J. Pharm. 36 (9): 1697-1908 (2017)  


REGULAR ARTICLES
 
Inhibiting Human Osteogenic Sarcoma Cell Growth In Vitro of Two Novel Pyran- Ketone Derivatives  *
YANG G., & HE J.  (1703)
 
 
Ursolic Acid: Inhibition of Renal Injury by Preventing Inflammatory and Fibrosis in GK Rats  *
CHEN X., SHI Y., TU H., CHENG X., ZHANG H., ZHANG Y., LV Z., QI Y., & HAN S.  (1709)
 
 
A Fast UPLC-MS/MS Method for the Quantitation of Darusentan in Rat Plasma: Application to a Pharmacokinetic Study  *
ZHOU Q., ZHOU Y., CHEN X. & HU G.  (1716)
 
 
Pharmacokinetics of Tramadol and its Metabolites Following Rectal Administration in Healthy Volunteers  *
SHAKYA S.R., KAEWNOPPARAT N., PHADOONGSOMBUT N., REANMONGKOL W. & WIWATTANAWONGSA K.  (1721)
 
 
Altered Metabolic Behavior of Derivatives of Herbal Compounds Used for Treatment of Carcinoma of Mouth  *
RUAN F., DAI J., YAN Q. & LU Y.  (1730)
 
 
Drug-Drug Interaction (DDI) Due to the Inhibition of Fusidic Acid  *
SHI, Y.  (1736)
 
 
Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents  *
WANG G., QIU J., CHEN M., XIAO X., CAO A. & LI L.  (1739)
 
 
The Influence of Mucopolysaccharide Polysulfate (MPS) on the Activity of Carboxylesterases (CES)  *
JIANG P.  (1746)
 
 
Drug-Drug Interaction Related with the Clinical Application of Lung Cancer Treatment Drug  *
FU G. & ZHANG Q.  (1749)
 
 
Exposure of Bisphenol A (BPA) Derivatives Affect the Metabolic Elimination of Alzheimer's Diseases Treatment Drugs  *
ZHU, G.  (1753)
 
 
Antibacterial Effect of Flavonoid 2,4-cis-3,4-cis-3,4,5,8-Tetramethoxy-[1",2":6,7]- Furanoflavan Against Pseudomonas aeruginosa  *
MEIRELES D.R.P., OLIVEIRA H.M.B.F., PIMENTA E.S., CRUZ R.M.C., FERNANDES L.M.D., GOUVEIA F.F.F., LIMA A.F., FILHO A.A.O. & LIMA E.O.  (1760)
 
 
Drug-Drug Interactions in the Treatment of Ovarian Cancer  *
HOU, L.  (1765)
 
 
Regorafenib Disturbs the Metabolism of Ticagrelor Catalyzed by UDP-Glucuronosyltransferase (UGT) 2B7  *
SUN H., LIU G., CAO H., XIAO S., WANG Y. & WANG Q.  (1769)
 
 
A Simplified, Highly Selective and Sensitive Method for Simultaneous Quantitation of Clevidipine and its Primary Metabolite H152/81 in Beagle Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Preclinical Bioequivalence Study  *
WANG Y., ZHAO L., YANG W., LI T., LI Q., SABI-MOUKA E.M.B., SUN L. & DING L.  (1774)
 
 
Drug-drug Interaction in the Treatment of Gastrointestinal Tumors  *
YANG, J.  (1784)
 
 
Diazotized Curcumin Containing Sulfonamides: Synthesis, Characterization and Antibacterial Activities  *
AHMED M., QADIR M.A., & SHAFIQ M.I.  (1789)
 
 
Co-Administration Risk Between Regorafenib and Irinotecan During the Therapy of Lung Cancer Patients  *
LI M., ZHANG X., SUN G., BAI Y. & LIU C.  (1796)
 
 
Lung Cancer Therapeutic Drug Vismodegib Showed Inhibition Potential Towards UDPGlucuronosyltransferase (UGT) 1A9  *
ZHAI S. & LI W.  (1801)
 
 
Liver Cancer Treatment Drug Irinotecan-Related Drug-Drug Interaction  *
LIU Y., YU H. & WANG X.  (1806)
 
 
Tumor Treatment Drugs-Related Drug-Drug Interaction (DDI) between Vismodegib and Irinotecan  *
YU J., WANG G., JIANG Y., JIANG Y., CAO Q., ZHANG X. & HAN J.  (1811)
 
 
Synthesis and Cytotoxicity of Tetrahydroisoquinoline Derivatives: Finding New Potential Anti-colorectal Cancer Drugs  *
LU M., DONG D., & ZHOU X.  (1816)
 
 
Protective Effects of Thevetiaflavone on H2O2-induced PC12 Cells Injury via Improving Oxidative Stress and Mitochondrial Dysfunction  *
YAO H., ZHANG X., WEI G., WU W., DUAN J., LI Y., ZHANG C. & LIU Y.  (1821)
 
 
Quantitative Determination of Brexpiprazole in Rat Plasma by UPLC-MS/MS and Application to a Pharmacokinetic Study  *
ZHANG X., ZHAN Y., HU X., FANG P. & QIAN J.  (1827)
 
 
Celastrol Inhibits Colorectal Cancer Cell Growth In Vivo by Regulation of miR-21  *
LU W., WANG K., ZHANG L., & PAN H.  (1833)
 
 
Edaravone Affects the Activity of Bone Cancer Treatment Relevant Enzyme UDP-Glucuronosyltransferase (UGT) 1A1  *
DONG Z., MA H. & MA H.  (1839)
 
 
Antitumor, Antioxidant and Chemical Constituents Identification of the Chloroform Extract of Wild Libyan Sonchus oleraceus  *
ABD EL-AZIM M.H.M. & SELIM Y.  (1843)
 
 
Behavior of Community Pharmacist of Buraydah city, Saudi Arabia, on Dispensing Antibiotics Without Prescription: A Cross-Sectional Study  *
AL-HARBI T.F., AL-HARBI M., ASDAQ S.M.B. & AL-YAMANI M.  (1849)
 
 
Investigation of the Inhibition of Nintedanib Towards the Activity of UDP-Glucuronosyltransferases (Ugts) Isoforms  *
FENG X. & MA H.  (1854)
 
 
Development and Validation of Analytical Methods for Telmisartan Quantification in Raw Material and in Tablets by UV-Spectrophotometer and HPLC  *
BORBA P.A.A., CAVALLERI C., PEZZINI B.R. & STULZER H.K.  (1858)
 
 
Beneficial Effect of Xanthohumol, a Prenylated Flavanoid, on 3-Nitropropionic Acid Induced Huntington's Disease in a Rat Model  *
ZHANG J., LI P., & WANG X.  (1867)
 
 
Development and Validation of a Method for the Simultaneous Analysis of Miconazole Nitrate and Hydrocortisone Acetate in Pharmaceutical Dosage Form by Ultraviolet Spectroscopy  *
REHMAN M.H., NAUREEN H., ABBAS N. & KHURSHEED M.  (1875)
 
 
Brain Metabolic Changes in Rats After Dextromethorphan  *
WU Q., HU Q., SUN F., DONG Y., WANG Q., MA J., WANG X. & ZHOU Y.  (1882)
 
 
Qualitative Evaluation of Over the Counter Medications among Undergraduate Students of Pharmacy  *
SHAHNAZ S., ARAIN M.I., GHOTO M.A. & DAYO A.  (1887)
 
 
Investigation on Regulation of Critical Hemodynamic Variables by Correlative Optimal Control Studies for Pharmacokinetic-Pharmacodynamic Model  *
SOWPARNIKA G.C., THIRUMARIMURUGAN M., SIVAKUMAR V.M., SARANYA S.N. & VINOTH N.  (1892)
 
 
Development, Validation and Pharmacokinetic Application of a Simple and Robust RPHPLC Method for Quantitation of Raloxifene in Rat Plasma  *
MAHMOOD S., SENGUPTA P., MANDAL U.K., CHATTERJEE B. & TAHER M.  (1901)
 



_________________

* English

** Portugûes

 
LOG-IN                                 

User


Password




Forgot your password?






ACTIONS ___     ___ _         

Submit Article

Check Manuscript Status

Suscription

Free Sample Issue



STATISTICS ___     ___        

JCR Impact Factor 2014:
0.372

Issues per year: 10

ISSN 0326 2383 (printed ed.)

ISSN 2362-3853 (on line ed.)
 




© Latin American Journal of Pharmacy 2017 | All rights reserved

Developed by: CAFFINI / COMMUNICATION & DESIGN